{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:29:21Z","timestamp":1768883361961,"version":"3.49.0"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["THA-118570"],"award-info":[{"award-number":["THA-118570"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191251","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T18:32:22Z","timestamp":1518114742000},"page":"e0191251","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study"],"prefix":"10.1371","volume":"13","author":[{"given":"Millicent","family":"Atujuna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0444-5915","authenticated-orcid":true,"given":"Peter A.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Eluhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Rubincam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"issue":"10013","key":"ref1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"S McCormack","year":"2015","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand pre-exposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"JM Molina","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"e1002099","DOI":"10.1371\/journal.pmed.1002099","article-title":"Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: a prospective implementation study in Kenya and Uganda","volume":"13","author":"JM Baeten","year":"2016","journal-title":"PLoS Med"},{"key":"ref4","article-title":"Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067\/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial","author":"LG Bekker","journal-title":"Lancet HIV"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"JM Baeten","year":"2016","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women","volume":"375","author":"A Nel","year":"2016","journal-title":"N Eng J Med"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"e60147","DOI":"10.1371\/journal.pone.0060147","article-title":"A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007)","volume":"8","author":"I McGowan","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"e0125363","DOI":"10.1371\/journal.pone.0125363","article-title":"A phase 1 randomized, open label, rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of three formulations of tenofovir 1% gel (the CHARM-01 Study)","volume":"10","author":"I McGowan","year":"2015","journal-title":"PLoS One"},{"issue":"23","key":"ref9","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref10","unstructured":"NIH National Institute of Allergy and Infectious Diseases. NIH-sponsored HIV vaccine trial launches in South Africa: early-stage trial aims to build on RV144 results. [cited 2015 Feb 18]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nih.gov\/news-events\/news-releases\/nih-sponsored-hiv-vaccine-trial-launches-south-africa\" xlink:type=\"simple\">https:\/\/www.nih.gov\/news-events\/news-releases\/nih-sponsored-hiv-vaccine-trial-launches-south-africa<\/ext-link>"},{"issue":"Suppl 1","key":"ref11","doi-asserted-by":"crossref","first-page":"17397","DOI":"10.7448\/IAS.15.3.17397","article-title":"Addressing the structural drivers of HIV: a luxury or necessity for programmes?","volume":"15","author":"J Seeley","year":"2012","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1521\/aeap.2007.19.4.346","article-title":"Structural violence against kothi-identified men who have sex with men in Chennai, India: a qualitative investigation","volume":"19","author":"V Chakrapani","year":"2007","journal-title":"AIDS Educ Prev"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2105\/AJPH.2005.074591","article-title":"Going beyond \u201cABC\u201d to include \u201cGEM\u201d: critical reflections on progress in the HIV\/AIDS epidemic","volume":"97","author":"SL Dworkin","year":"2007","journal-title":"Am J Public Health"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"20646","DOI":"10.7448\/IAS.19.1.20646","article-title":"Structural drivers and social protection: mechanisms of HIV risk and HIV prevention for South African adolescents","volume":"19","author":"LD Cluver","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1525\/9780520940451","article-title":"When bodies remember: experiences and politics of AIDS in South Africa","author":"D Fassin","year":"2007"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.socscimed.2006.09.015","article-title":"The changing political economy of sex in South Africa: The significance of unemployment and inequalities to the scale of the AIDS pandemic","volume":"64","author":"M Hunter","year":"2007","journal-title":"Soc Sci Med"},{"key":"ref17","first-page":"xii","article-title":"WHO consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations","year":"2016"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"JM Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"L Van Damme","year":"2012","journal-title":"N Engl J Med"},{"issue":"3 Suppl 2","key":"ref20","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.7448\/IAS.17.3.19146","article-title":"Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa","volume":"17","author":"A van der Straten","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"e89118","DOI":"10.1371\/journal.pone.0089118","article-title":"Women\u2019s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa","volume":"9","author":"A van der Straten","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/14760584.2016.1118349","article-title":"Taking culture seriously in biomedical HIV prevention trials: a meta-synthesis of qualitative studies","volume":"15","author":"C Rubincam","year":"2016","journal-title":"Expert Rev Vaccine"},{"issue":"39","key":"ref23","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1016\/j.vaccine.2014.07.018","article-title":"Development of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICES","volume":"32","author":"S-J Lee","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s10461-015-1258-9","article-title":"Acceptability and preferences for hypothetical rectal microbicides among a community sample of young men who have sex with men and transgender women in Thailand: a discrete choice experiment","volume":"20","author":"PA Newman","year":"2016","journal-title":"AIDS Behav"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/apc.2004.18.691","article-title":"Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?","volume":"18","author":"PA Newman","year":"2004","journal-title":"AIDS Patient Care STDs"},{"issue":"20","key":"ref26","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/j.vaccine.2008.03.004","article-title":"What can HIV vaccine trials teach us about dissemination?","volume":"26","author":"PA Newman","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jama.2007.26","article-title":"The meaning of translational research and why it matters","volume":"299","author":"SH Woolf","year":"2008","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"D135","DOI":"10.1016\/j.vaccine.2011.07.027","article-title":"From smallpox eradication to contemporary global health initiatives: enhancing human capacity towards a global public health goal","volume":"29S","author":"D Tarantola","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"e28238","DOI":"10.1371\/journal.pone.0028238","article-title":"Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study","volume":"7","author":"AB Eisingerich","year":"2012","journal-title":"PloS One"},{"issue":"36","key":"ref30","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1016\/j.vaccine.2013.05.089","article-title":"The marginal willingness-to-pay for attributes of a hypothetical HIV vaccine","volume":"31","author":"MP Cameron","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/QAI.0b013e3181e1e2c0","article-title":"Barriers to adolescents\u2019 participation in HIV biomedical prevention research","volume":"54","author":"RJ DiClemente","year":"2010","journal-title":"J Acquir Immun Defic Syndr"},{"issue":"Suppl 2","key":"ref32","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1097\/QAI.0b013e31829871fb","article-title":"Preventing HIV among young people: research priorities for the future","volume":"63","author":"A Pettifor","year":"2013","journal-title":"J Acquir Immun Defic Syndr"},{"issue":"9839","key":"ref33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(12)60955-6","article-title":"Successes and challenges of HIV prevention in men who have sex with men","volume":"380","author":"PS Sullivan","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1164\/rccm.201004-0598OC","article-title":"Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township","volume":"182","author":"K Middelkoop","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1186\/1471-2458-11-766","article-title":"HIV risk and associations of HIV infection among men who have sex with men in peri-urban Cape Town, South Africa","volume":"11","author":"S Baral","year":"2011","journal-title":"BMC Public Health"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"e000004","DOI":"10.1136\/bmjgh-2015-000004","article-title":"Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave","volume":"1","author":"BC Zanoni","year":"2016","journal-title":"BMJ Glob Health"},{"issue":"27","key":"ref37","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"RM Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"ref38","unstructured":"Rees H, Delany-Moretlwe SA, Lombard C, Baron D, Panchia R, Myer L, et al. FACTS 001 Phase III Trial of pericoital tenofovir 1% gel for HIV prevention in women [abstract]. 2015 Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, USA. 2015;26LB."},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"Safety and efficacy of the HVTN 503\/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11","author":"GE Gray","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref40","article-title":"Qualitative research practice: a guide for social science students and researchers","author":"J Ritchie","year":"2003"},{"key":"ref41","first-page":"194","article-title":"South African national HIV prevalence, incidence and behaviour survey, 2012","author":"O Shisana","year":"2014"},{"issue":"3 Suppl 2","key":"ref42","doi-asserted-by":"crossref","first-page":"19157","DOI":"10.7448\/IAS.17.3.19157","article-title":"The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study","volume":"17","author":"N Mack","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/21528586.2001.10419031","article-title":"Understanding young women\u2019s risk for HIV\/AIDS: adolescent sexuality and vulnerability in rural KwaZulu\/Natal","volume":"31","author":"A Harrison","year":"2001","journal-title":"Soc Transit"},{"issue":"3","key":"ref44","first-page":"45","article-title":"Sexual decision-making and negotiation in the midst of AIDS: youth in KwaZulu\/Natal, South Africa","volume":"7","author":"CA Varga","year":"1997","journal-title":"Health Transit Rev"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2989\/16085906.2003.9626563","article-title":"Contexts of vulnerability: sex, secrecy and HIV\/AIDS","volume":"2","author":"EM Preston-Whyte","year":"2003","journal-title":"Afr J AIDS Res"},{"issue":"1","key":"ref46","first-page":"1","article-title":"Youth, HIV\/AIDS and the importance of sexual culture context","volume":"28","author":"SL Madlala","year":"2002","journal-title":"Soc Dynamics"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"20875","DOI":"10.7448\/IAS.19.1.20875","article-title":"Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study","volume":"19","author":"EH Luecke","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10461-016-1458-y","article-title":"Experiences with HTPN 067\/ADAPT study-provided open-label PrEP among women in Cape Town: facilitators and barriers within a mutually framework","volume":"21","author":"KR Amico","year":"2017","journal-title":"AIDS Behav"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1472-6874-12-40","article-title":"An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana","volume":"12","author":"MA Abdulai","year":"2012","journal-title":"BMC Women\u2019s Health"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/13691058.2011.630099","article-title":"Variations in microbicide gel acceptability among young women in the USA and Puerto Rico","volume":"14","author":"R Giguere","year":"2012","journal-title":"Cult Health Sex"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/09540121.2012.722604","article-title":"How effective is effective enough? Opinions of potential end-users of microbicides from a rural South African community","volume":"25","author":"M Gafos","year":"2013","journal-title":"AIDS Care"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1090198109335654","article-title":"Future HIV vaccine acceptability among young adults in South Africa","volume":"37","author":"JN Sayles","year":"2010","journal-title":"Health Educ Behav"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/j.1475-6773.2009.01039.x","article-title":"Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (L.A. VOICES)","volume":"44","author":"PA Newman","year":"2009","journal-title":"Health Serv Res"},{"issue":"12","key":"ref54","first-page":"1662","article-title":"HIV vaccine knowledge and beliefs among communities at elevated risk: Conspiracies, questions and confusion","volume":"97","author":"KJ Roberts","year":"2005","journal-title":"J Natl Med Assoc"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"e1001472","DOI":"10.1371\/journal.pmed.1001472","article-title":"prevalence of consensual male\u2013male sex and sexual violence, and associations with HIV in South Africa: a population-based cross-sectional study","volume":"10","author":"KL Dunkle","year":"2013","journal-title":"PLoS Med"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1521\/aeap.2016.28.1.1","article-title":"To use a rectal microbicide, first insert the applicator: gel and applicator satisfaction among young men who have sex with men","volume":"28","author":"J Bauermeister","year":"2016","journal-title":"AIDS Educ Prev"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.2105\/AJPH.2013.301731","article-title":"Preparing for rectal microbicides: sociocultural factors affecting product uptake among potential South American users","volume":"104","author":"JT Galea","year":"2014","journal-title":"Am J Public Health"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"18476","DOI":"10.7448\/IAS.16.1.18476","article-title":"A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thailand","volume":"16","author":"PA Newman","year":"2013","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"ref59","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1177\/1049732317697947","article-title":"\u201cLike holding an umbrella before it rains\u201d: acceptability of future rectal microbicides among men who have sex with men in India-a modified Technology Acceptance Model","volume":"27","author":"V Chakrapani","year":"2017","journal-title":"Qual Health Res"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.socscimed.2004.12.024","article-title":"The social structural production of HIV risk among injecting drug users","volume":"61","author":"T Rhodes","year":"2005","journal-title":"Soc Sci Med"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2190\/HS.39.3.a","article-title":"What we mean by social determinants of health","volume":"39","author":"V Navarro","year":"2009","journal-title":"Int J Health Serv"},{"issue":"7387","key":"ref62","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/bmj.326.7387.495","article-title":"The politics of AIDS in South Africa: beyond the controversies","volume":"326","author":"D Fassin","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/erv.11.162","article-title":"Integrating social and biomedical science in HIV vaccine research: obstacles, opportunities and ways forward","volume":"11","author":"PA Newman","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref64","unstructured":"UNAIDS. Fast-tracking combination prevention: towards reducing new HIV infections to fewer than 500,000 by 2020. [cited 2015 Oct] <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20151019_JC2766_Fast-tracking_combination_prevention.pdf\" xlink:type=\"simple\">http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20151019_JC2766_Fast-tracking_combination_prevention.pdf<\/ext-link>"},{"issue":"9787","key":"ref65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(11)60877-5","article-title":"HIV prevention transformed: the new prevention research agenda","volume":"378","author":"NS Padian","year":"2011","journal-title":"Lancet"},{"key":"ref66","unstructured":"Medicines Control Council. Press release: Medicines Control Council approves fixed-dose combination of tenofovir disoproxyl fumarate and emtricitabine for pre-exposure prophylaxis of HIV. [cited 2015 Dec 3]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.mccza.com\/documents\/2e4b3a5310.11_Media_release_ARV_FDC_PrEP_Nov15_v1.pdf\" xlink:type=\"simple\">http:\/\/www.mccza.com\/documents\/2e4b3a5310.11_Media_release_ARV_FDC_PrEP_Nov15_v1.pdf<\/ext-link>"},{"key":"ref67","unstructured":"Harrington M. Introduction and executive summary. In Treatment Action Group, Pipeline Report 2017: HIV-TB-HCV\u2013drugs, diagnostics, vaccines, preventive technologies, cure research, and immune-based and gene therapies in development. Pipeline Report [cited 2017 Jul]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.pipelinereport.org\/2017\/toc\" xlink:type=\"simple\">http:\/\/www.pipelinereport.org\/2017\/toc<\/ext-link>"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T02:24:39Z","timestamp":1719800679000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191251"}},"subtitle":[],"editor":[{"given":"Garrett","family":"Prestage","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191251","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]}}}